A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/1997
12/11/1997	WO1997046687A1 Vectors comprising sar elements
12/11/1997	WO1997046673A2 Inhibition of hiv-1 replication by antisense rna expression
12/11/1997	WO1997046671A1 Enhanced efficacy of liposomal antisense delivery
12/11/1997	WO1997046581A1 Viral peptides with structural homology to protein g of respiratory syncytial virus
12/11/1997	WO1997046564A1 Novel water-soluble analogues of 20(s)-camptothecin
12/11/1997	WO1997046563A1 Novel water-soluble c-ring analogues of 20 (s)-camptothecin
12/11/1997	WO1997046562A1 Novel water-soluble c-ring analogues of 20(s)-camptothecin
12/11/1997	WO1997046522A1 Novel vitamin d analogues
12/11/1997	WO1997046255A2 Vaccine composition comprising outer membrane protein fragments of bordetella pertussis
12/11/1997	WO1997046237A1 Anti-viral compounds
12/11/1997	WO1997046235A1 Anti-viral compounds
12/11/1997	WO1997046204A2 Injectable compositions
12/11/1997	WO1997041252A3 Dna, rna and a protein useful for detection of a mycobacterial infection
12/11/1997	CA2259469A1 Injectable compositions
12/11/1997	CA2257943A1 Viral peptides with structural homology to protein g of respiratory syncytial virus
12/11/1997	CA2257551A1 Process for producing high-molecular-weight compounds of phenolic compounds, etc. and use thereof
12/11/1997	CA2257389A1 Virus-like particles useful as a vector for delivering nucleic acid
12/11/1997	CA2257296A1 Anti-viral compounds
12/11/1997	CA2256484A1 Vectors comprising sar elements
12/11/1997	CA2256456A1 Enhanced efficacy of liposomal antisense delivery
12/11/1997	CA2254993A1 Anti-viral compounds
12/11/1997	CA2254819A1 Inhibition of hiv-1 replication by antisense rna expression
12/10/1997	EP0811696A2 Method to obtain nucleotide sequence using randomly primed amplification
12/10/1997	EP0811688A2 Staphylococcus aureus RNase P
12/10/1997	EP0811613A1 Antibiotic Quinolones and derivatives
12/10/1997	EP0811600A2 Anti-viral compounds
12/10/1997	EP0811599A2 Anti-viral compounds
12/10/1997	EP0811160A1 Nf-kappa b activation regulatory protein, i-kappa b-beta
12/10/1997	EP0811078A1 Bcr-abl directed compositions and uses for inhibiting philadelphia chromosome stimulated cell growth
12/10/1997	EP0811071A1 Amplifier sequences derived from the desmin gene, vectors comprising same and uses thereof for producing proteins
12/10/1997	EP0811067A1 Equine arteritis virus peptides, antibodies and their use in a diagnostic test
12/10/1997	EP0811066A1 Dna molecule encoding for cellular uptake of mycobacterium tuberculosis and uses thereof
12/10/1997	EP0811063A2 Chemokine receptors 88-2b ckr-3] and 88c and their antibodies
12/10/1997	EP0811060A1 EUKARYOTIC INITIATION FACTOR 5A (eIF-5A) MUTANTS
12/10/1997	EP0811011A1 Carbohydrate conjugated bio-active compounds
12/10/1997	EP0811009A1 Stable hydrates of a cephalosporin chloride salt
12/10/1997	EP0810877A1 Hepatitis b vaccine
12/10/1997	EP0810875A1 Multifunctional enzyme
12/10/1997	EP0810873A1 Antiviral combinations of bch-189 and ritonavir
12/10/1997	EP0810865A1 Novel pharmaceutical composition
12/10/1997	EP0810864A1 2,6-diaryl pyridazinones with immunosuppressant activity
12/10/1997	EP0693071B1 New carboxylic-acid esters of 2-amino-7-(1,3-dihydroxy-2-propoxymethyl)purine, the preparation of such esters and their use
12/10/1997	EP0659180B1 Anti-viral sulfur-analogues of 1,5-dideoxy-1,5-imino-d-glucitol (deoxynojirimycin)
12/10/1997	CN1167505A Tie-2 ligands, methods of making and uses thereof
12/10/1997	CN1167486A 2-(pyrazol-3-yl) garbapenem derivatives
12/10/1997	CN1167442A Composition for prevention and treatment of HIV-1 infection comprising at least two different HIV-1 reverse transcriptase inhibitors
12/10/1997	CN1167146A Lawsonia intracellularis cultivation, anti-lawsonia intracellularis vaccines and diagnostic agents
12/09/1997	US5696263 Antiviral acyclic phosphonomethoxyalkylsubstituted alkenyl and alkynyl purine and pyrimidine derivatives
12/09/1997	US5696254 Processes for the diastereoselective synthesis of nucleoside analogues
12/09/1997	US5696248 Gene expression inhibitor, as probes for detecting nucleic acids, as viricides treating viral disease caused by htlv, influenza, hepatitis virus, papilloma virus
12/09/1997	US5696244 Chelation; protection; acylation with acetic acid and triacetoxy sodium borohydride
12/09/1997	US5696237 Recombinant antibody-toxin fusion protein
12/09/1997	US5696151 Compounds useful for the inhibition of the replication of HIV-1 and HIV-1 mutants
12/09/1997	US5696132 Microbiocides
12/09/1997	US5696117 Benzoxazine antimicrobial agents
12/09/1997	US5696098 Additives to bactericides, cosmetics
12/09/1997	US5696096 Pradimicin derivatives
12/09/1997	US5696095 Contains potassium acesulfame; masks bitterness without adversely affecting bioavailability or stability
12/09/1997	US5696090 Pharmaceutical composition
12/09/1997	US5696088 Chimeric proteins
12/09/1997	US5696076 5-lipoxygenase-activating protein II
12/09/1997	US5696000 Adhesion receptors for pathogenic or opportunistic microorganisms
12/09/1997	US5695991 A complex between a virus the cell binding receptor of which has been inactivated and an antibody able to interact with specific antigen; antigen has ability to mediate entrance into mammalian cells
12/09/1997	US5695983 Mutant cells; genetic engineering
12/09/1997	US5695931 Nucleotide sequences coding for a protein with urease activity
12/09/1997	US5695770 Induction of cytotoxic T-lymphocyte responses
12/09/1997	US5695767 Live, attenuated rotavirus which stimulates antibody production
12/09/1997	US5695766 Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome
12/09/1997	US5695760 Modified anti-ICAM-1 antibodies and their use in the treatment of inflammation
12/09/1997	US5695755 Peripheralization of hematopoietic stem cells
12/07/1997	CA2195036A1 Bacteriocidal, antibacterial and bacteriostatic composition
12/06/1997	CA2206914A1 Antibiotic quinolones and derivatives
12/04/1997	WO1997045444A1 Ebv ctl epitopes
12/04/1997	WO1997045437A1 Compositions and methods for antisense inhibition of protein translation
12/04/1997	WO1997045430A1 Carbapenem antibiotic, composition and method of preparation
12/04/1997	WO1997045429A1 Beta-lactams
12/04/1997	WO1997045139A2 Il-12 as an adjuvant for bordetella pertussis vaccines
12/04/1997	WO1997045136A1 Lactoferrin variants and uses thereof
12/04/1997	WO1997045132A1 Antiviral agent, process for production thereof, and application thereof
12/04/1997	WO1997045105A1 Compositions and methods for treating or preventing diseases of body passageways
12/04/1997	WO1997038689A3 Enteric-coated pharmaceutical compositions of mycophenolate
12/04/1997	CA2256453A1 Lactoferrin variants and uses thereof
12/04/1997	CA2256358A1 Compositions and methods for antisense inhibition of protein translation
12/04/1997	CA2255927A1 Ebv ctl epitopes
12/04/1997	CA2254943A1 Beta-lactams
12/03/1997	EP0810209A2 Alpha - and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
12/03/1997	EP0809996A2 Interferon conjugates
12/03/1997	EP0809708A1 Potentiators of antibacterial agents
12/03/1997	EP0809700A1 Papilloma virus-like particles, fusion proteins and process for producing the same
12/03/1997	EP0809695A1 Transcription factor - e2f-5
12/03/1997	EP0809653A1 Helicobacter pylori antigen
12/03/1997	EP0809636A1 Substituted isoxazoles for the treatment of inflammation
12/03/1997	EP0809511A1 Inhibition of angiogenesis using interleukin-12
12/03/1997	EP0809506A2 Antimicrobial composition composed of controlled release glasses
12/03/1997	EP0809504A1 Anti-viral triaza compounds
12/03/1997	EP0809501A1 Novel pharmaceutical formulation
12/03/1997	EP0809500A1 Novel glucocorticoid response elements
12/03/1997	EP0809499A1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine
12/03/1997	EP0809498A1 Novel pharmaceutical combination
12/03/1997	EP0597852B1 Swine pneumonia vaccine and method for the preparation thereof

1 ... 1566 1567 1568 1569 1570 1571 1572 1573 1574 1575 1576 1577 1578 1579 1580 1581 1582 1583 1584 1585 1586 ... 1798